MARKET

TTRX

TTRX

Turn Therapeutics Inc
NASDAQ
3.635
-0.675
-15.66%
Opening 13:30 12/08 EST
OPEN
4.370
PREV CLOSE
4.310
HIGH
4.370
LOW
3.520
VOLUME
80.37K
TURNOVER
--
52 WEEK HIGH
26.50
52 WEEK LOW
2.570
MARKET CAP
107.03M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TTRX last week (1201-1205)?
Weekly Report · 8h ago
Weekly Report: what happened at TTRX last week (1124-1128)?
Weekly Report · 12/01 10:38
Director Arthur F. Golden Acquires Common Shares of Turn Therapeutics Inc
Reuters · 11/26 02:00
Director Arthur F. Golden Reports Acquisition of Turn Therapeutics Inc. Common Shares
Reuters · 11/24 16:20
Weekly Report: what happened at TTRX last week (1117-1121)?
Weekly Report · 11/24 10:45
Turn Therapeutics Inc. Officer Zuraiz Chaudhary Reports Acquisition of Common Shares
Reuters · 11/21 22:44
Interim CFO Zuraiz Chaudhary Acquires Common Shares of Turn Therapeutics Inc
Reuters · 11/18 02:24
Weekly Report: what happened at TTRX last week (1110-1114)?
Weekly Report · 11/17 10:45
More
About TTRX
Turn Therapeutics Inc. is a pharmaceutical and medical device development company built around a proprietary platform of technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.

Webull offers Turn Therapeutics Inc stock information, including NASDAQ: TTRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TTRX stock methods without spending real money on the virtual paper trading platform.